Share Name Share Symbol Market Type Share ISIN Share Description
Angle Plc LSE:AGL London Ordinary Share GB0034330679 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.50p -0.96% 51.50p 50.00p 53.00p 52.00p 51.50p 52.00p 7,304 08:36:54
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Support Services 0.5 -7.4 -8.7 - 60.30

Angle Share Discussion Threads

Showing 47651 to 47674 of 47675 messages
Chat Pages: 1907  1906  1905  1904  1903  1902  1901  1900  1899  1898  1897  1896  Older
DateSubjectAuthorDiscuss
16/1/2018
09:28
Wonder if this was listed in USA and not UK would it's value be a lot higher ?
dave4545
16/1/2018
07:10
RNS Number : 9414B Angle PLC 16 January 2018 For immediate release 16 January 2018 ANGLE plc ("the Company") WEBINAR: USING THE PARSORTIXTM SYSTEM TO IDENTIFY DRUGS THAT MAY ARREST CANCER METASTASIS ANGLE plc (AIM:AGL OTCQX:ANPCY), a world-leading liquid biopsy company, announces that Professor Stuart Martin from the University of Maryland School of Medicine, USA, will be presenting a webinar describing his breakthrough work using the ParsortixTM system to test drugs on live circulating tumor cells (CTCs) as was described in the Company's announcement on 9 October 2017. The webinar is intended for cancer researchers but is also open to investors and other interested parties. The details are as follows: "Microfluidic Cell Tethering Enables Rapid Analysis of Drug Responses in Live Patient CTCs" Wednesday 17 January 2018 from 5pm to 5:50pm UK time. Participants need to register in advance using the following link hTTps://register.gotowebinar.com/register/5646294960950153218 Over 90% of deaths from cancer arise from the process of metastasis where the cancer spreads throughout the body via CTCs in the blood causing secondary cancers. If drugs can be identified for the patient that disable their CTCs then the metastatic spread of the disease might be arrested or reduced.
mikepompeyfan
15/1/2018
16:22
Near 10% published spread. Anyone would think they didn't want to attract any action!
waterloo01
15/1/2018
13:14
You may well be right SV, it looks like MD have been doing a lot of Parsortux enabled research relating to CRC and its treatment so there may indeed be more to come. Alternatively it may be that MD are going to present their work at one if the forthcoming conferences and AGL are holding off till then.
miavoce
15/1/2018
11:07
Miavoce - I am speculating that there may be a bit more to come with your find as it hasn’t even been tweeted.
semper vigilans
13/1/2018
09:56
I’ll leave that to you Miavoce - I’d be a fraud allying myself to anything with ‘scholar’; in it!
semper vigilans
13/1/2018
09:51
Thanks Miavoce - useful!
bermudashorts
13/1/2018
09:29
Thanks Miavoce - good news for Parsortix - money well spent by AGL in part funding this.
semper vigilans
13/1/2018
09:22
I have subscribed to google scholar alerts to be alerted whenever an academic article us published which mentions Parsortix. If you want to do the same just Google 'Google scholar' and it is straightforward after that.
miavoce
13/1/2018
08:58
Good spot miavoce
bermudashorts
13/1/2018
08:53
Says published online 01/12/2017
elbillo
13/1/2018
08:34
This seems to relate to the work started with MD Anderson which was announced a couple of years ago (focused on Colorectal Cancer and cetuximab). Maybe we will get an announcement on Monday (assuming Angle are aware).hTTps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5752698/
miavoce
12/1/2018
12:20
Drug companies might like this very much because having live CTCs will make it easier to trial and test their new drugs for effectiveness.
chippyfriday
12/1/2018
09:29
Picked up a few more for my wife's ISA. 20k @ 51.6
outsizeclothes.com
12/1/2018
09:15
Might we finally be moving? Not many left at 54p
waterloo01
12/1/2018
06:18
The drug companies won't like it because it means they will sell less of their pointless expensive drugs as only the ones that work will be used. Health Treatment providers will love it because of the savings they will make on wasted drugs. Cancer sufferers will love it for obvious reasons. As you say it's great news (if true) and a potential game changer. Exciting stuff.
mikepompeyfan
11/1/2018
19:32
"showcase a case study on the rapid analysis of tethered patient tumor cells to potentially predict outcome and drug response." Can you imagine the potential uses. What drug company or funder, NHS or otherwise, wouldn't like to be able to predict who is going to respond to which drug, and equally who won't, simply by making it interact with a live cell (and I've no idea how but hope to be more enlightened come the 17th). The savings would be enormous both in terms of lives but also money. Maybe the FDA would license it for this use as an easy win. (Not forgetting breast, ovarian and prostate cancers). This feels a little IMM like to me. Wouldn't move from 50p range for ages, then.......
waterloo01
11/1/2018
19:22
Not sure whether this has already been posted but Angle are presenting at a Shares Investor Evening in Manchester on 20th Feb. hxxps://www.sharesmagazine.co.uk/events/event/shares-investor-evening-manchester-200218
bermudashorts
11/1/2018
09:40
A touch of magic next week? htTps://register.gotowebinar.com/register/5646294960950153218?utm_source=Twitter&utm_campaign=Twitter This webinar will explain the current limits of clinical imaging that shape our understanding of cancer recurrence, explore microtentacle cytoskeletal behavior in circulating tumor cells and showcase a case study on the rapid analysis of tethered patient tumor cells to potentially predict outcome and drug response.
waterloo01
11/1/2018
09:05
Unfortunately I understood and remembered the reference!
waterloo01
11/1/2018
09:02
Showing your age there Semper lol
willfy
11/1/2018
07:41
Sorry missed your f out ..fat fingers
life guard
11/1/2018
07:40
Willy in the past announcements have been made. We are all waiting for the start of the breast cancer trial so it might be that.
life guard
11/1/2018
06:46
My mistake then, was rather hoping their would have been a major announcement, with the webcast ....
willfy
Chat Pages: 1907  1906  1905  1904  1903  1902  1901  1900  1899  1898  1897  1896  Older
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:33 V: D:20180116 09:34:25